Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria
- PMID: 19560030
- DOI: 10.1016/j.jvir.2009.04.021
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria
Abstract
The field of interventional oncology includes tumor ablation as well as the use of transcatheter therapies such as embolization, chemoembolization, and radioembolization. Terminology and reporting standards for tumor ablation have been developed. The development of standardization of terminology and reporting criteria for transcatheter therapies should provide a similar framework to facilitate the clearest communication among investigators and provide the greatest flexibility in comparing established and emerging technologies. An appropriate vehicle for reporting the various aspects of catheter directed therapy is outlined, including classification of therapies and procedure terms, appropriate descriptors of imaging guidance, and terminology to define imaging and pathologic findings. Methods for standardizing the reporting of outcomes toxicities, complications, and other important aspects that require attention when reporting clinical results are addressed. It is the intention of the group that adherence to the recommendations will facilitate achievement of the group's main objective: improved precision and communication for reporting the various aspects of transcatheter management of hepatic malignancy that will translate to more accurate comparison of technologies and results and, ultimately, to improved patient outcomes.
Republished from
-
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria.J Vasc Interv Radiol. 2007 Dec;18(12):1469-78. doi: 10.1016/j.jvir.2007.08.027. J Vasc Interv Radiol. 2007. PMID: 18057279 Review.
Similar articles
-
Transcatheter therapy for hepatic malignancy: standardization of terminology and reporting criteria.J Vasc Interv Radiol. 2007 Dec;18(12):1469-78. doi: 10.1016/j.jvir.2007.08.027. J Vasc Interv Radiol. 2007. PMID: 18057279 Review.
-
Image-guided tumor ablation: standardization of terminology and reporting criteria.J Vasc Interv Radiol. 2009 Jul;20(7 Suppl):S377-90. doi: 10.1016/j.jvir.2009.04.011. J Vasc Interv Radiol. 2009. PMID: 19560026
-
Image-guided tumor ablation: standardization of terminology and reporting criteria.J Vasc Interv Radiol. 2005 Jun;16(6):765-78. doi: 10.1097/01.RVI.0000170858.46668.65. J Vasc Interv Radiol. 2005. PMID: 15947040
-
Image-guided tumor ablation: proposal for standardization of terms and reporting criteria.Radiology. 2003 Aug;228(2):335-45. doi: 10.1148/radiol.2282021787. Radiology. 2003. PMID: 12893895
-
Image-guided tumor ablation: standardization of terminology and reporting criteria.Radiology. 2005 Jun;235(3):728-39. doi: 10.1148/radiol.2353042205. Epub 2005 Apr 21. Radiology. 2005. PMID: 15845798 Free PMC article. Review.
Cited by
-
Chemical Shift MRI Monitoring of Chemoembolization Delivery for Hepatocellular Carcinoma: Multicenter Feasibility of Initial Clinical Translation.Radiol Imaging Cancer. 2023 May;5(3):e220019. doi: 10.1148/rycan.220019. Radiol Imaging Cancer. 2023. PMID: 37233207 Free PMC article.
-
TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC.Biol Proced Online. 2023 May 19;25(1):13. doi: 10.1186/s12575-023-00199-x. Biol Proced Online. 2023. PMID: 37208604 Free PMC article.
-
Balloon-occluded transarterial chemoembolization versus conventional transarterial chemoembolization for the treatment of single hepatocellular carcinoma: a propensity score matching analysis.Eur Radiol. 2023 Apr;33(4):2655-2664. doi: 10.1007/s00330-022-09284-3. Epub 2022 Dec 6. Eur Radiol. 2023. PMID: 36472699
-
Surgical Resection plus Intraoperative Radiofrequency Ablation versus Chemoembolization for the Treatment of Intermediate-Stage (BCLC B) Hepatocellular Carcinoma with Preserved Liver Function: A Propensity Score-Matched Analysis.Cancers (Basel). 2022 May 15;14(10):2440. doi: 10.3390/cancers14102440. Cancers (Basel). 2022. PMID: 35626044 Free PMC article.
-
Chemoembolization for Single Large Hepatocellular Carcinoma with Preserved Liver Function: Analysis of Factors Predicting Clinical Outcomes in a 302 Patient Cohort.Life (Basel). 2021 Aug 17;11(8):840. doi: 10.3390/life11080840. Life (Basel). 2021. PMID: 34440584 Free PMC article.
LinkOut - more resources
Full Text Sources